Literature DB >> 26994411

Low- and high-risk human papillomavirus genotype infections in intra-anal warts in HIV-positive men who have sex with men.

M L Siegenbeek van Heukelom1,2,3, O Richel4,5, H J C de Vries5,6,7, M M van de Sandt8, S Beck8, H A M van den Munckhof8, E C Pirog9, M N C de Koning8, J M Prins4,5, K D Quint8,10,11.   

Abstract

BACKGROUND: Anogenital warts are often presumed to represent nondysplastic or low-grade anal intraepithelial neoplasia (LGAIN). We previously demonstrated that up to 20% of intra-anal warts in HIV-positive men who have sex with men (MSM) contain regions of high-grade AIN (HGAIN).
OBJECTIVES: To determine the causative human papillomavirus (HPV) types of low- and high- grade dysplastic areas in warts from HIV-positive MSM.
METHODS: A total of 42 intra-anal warts from 41 HIV-positive MSM were graded as nondysplastic, LGAIN or HGAIN. Whole-tissue sections (WTS) were analysed with the SPF10 polymerase chain reaction/LiPA25 HPV genotyping system. If the WTS contained multiple HPV types, dysplastic regions were isolated by laser capture microdissection (LCM) for HPV genotyping.
RESULTS: Overall, 38 of 42 (91%) WTS tested positive for HPV DNA. Of these, 23 (61%) contained a single HPV type and 15 (39%) contained multiple HPV types. All LCM-selected regions contained no more than one HPV type. Ten of 42 (24%) WTS contained HGAIN disease, of which six (60%) were associated with a high-risk HPV (hrHPV) genotype. Twenty-three of 42 WTS contained LGAIN disease, of which two (9%) were associated with hrHPV. AIN lesions containing hrHPV types were identified using p16 staining.
CONCLUSIONS: LGAIN lesions can be caused by high-risk HPV genotypes and vice versa. We therefore recommend routine follow-up and treatment of all dysplastic intra-anal warts for HIV-positive MSM.
© 2016 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26994411     DOI: 10.1111/bjd.14567

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  [Genital warts in HIV-infected individuals].

Authors:  U Wieland; A Kreuter
Journal:  Hautarzt       Date:  2017-03       Impact factor: 0.751

Review 2.  [Anal dysplasia and anal cancer].

Authors:  Ulrike Wieland; Frank Oellig; Alexander Kreuter
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

Review 3.  Anal dysplasia and anal cancer. English version.

Authors:  Ulrike Wieland; Frank Oellig; Alexander Kreuter
Journal:  Hautarzt       Date:  2020-12       Impact factor: 0.751

4.  Multiple HPV infections among men who have sex with men engaged in anal cancer screening in Abuja, Nigeria.

Authors:  Rebecca G Nowak; Lisa M Schumaker; Nicholas P Ambulos; Nicaise Ndembi; Wuese Dauda; Chinedu H Nnaji; Andrew Mitchell; Trevor J Mathias; Paul Jibrin; Teresa M Darragh; Oluwole Olaomi; Trevor A Crowell; Stefan D Baral; Manhattan E Charurat; Søren M Bentzen; Joel M Palefsky; Kevin J Cullen
Journal:  Papillomavirus Res       Date:  2020-05-31

5.  Grading immunohistochemical markers p16INK4a and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions.

Authors:  A Leeman; D Jenkins; E Marra; M van Zummeren; E C Pirog; M M van de Sandt; A van Eeden; M F Schim van der Loeff; J Doorbar; H J C de Vries; F J van Kemenade; C J L M Meijer; W G V Quint
Journal:  Br J Dermatol       Date:  2019-10-02       Impact factor: 9.302

6.  Squamous intraepithelial lesions of the anal squamocolumnar junction: Histopathological classification and HPV genotyping.

Authors:  Omar Clavero; Jenny McCloskey; Vicente Marco Molina; Beatriz Quirós; Ignacio G Bravo; Silvia de Sanjosé; F Xavier Bosch; Ville N Pimenoff
Journal:  Papillomavirus Res       Date:  2016-12-09

7.  Multiple types of human papillomavirus infection and anal precancerous lesions in HIV-infected men in Taiwan: a cross-sectional study.

Authors:  Shu-Hsing Cheng; Kuo-Sheng Liao; Chi-Chao Wang; Chien-Yu Cheng; Fang-Yeh Chu
Journal:  BMJ Open       Date:  2018-01-27       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.